Memorandum from Dr. Glenda Mock, Principal Medical Officer, to Chief Medical Officer and Mrs Angela Smith, re vCJD and plasma - products for patient notification. Outlines the proposed plan of action for notifying patients who have received plasma products potentially contaminated with vCJD.